(Q40125164)

17 September 2017

title

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei (English)

1 reference

17 September 2017

0 references

1 reference

2

1 reference

17 September 2017

6

1 reference

17 September 2017

Arturo Reyes-Sandoval

object named as

Arturo Reyes-Sandoval

series ordinal

1

0 references

John T. Harty

object named as

John T Harty

series ordinal

5

0 references

Adrian V. S. Hill

series ordinal

10

object named as

Adrian V S Hill

1 reference

17 September 2017

3

Tamara Berthoud

1 reference

17 September 2017

4

Anne C Moore

1 reference

17 September 2017

7

Guangping Gao

1 reference

17 September 2017

8

Hildegund C J Ertl

1 reference

17 September 2017

James C Wilson

9

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

European Journal of Immunology

17 September 2017

published in

1 reference

17 September 2017

volume

38

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

732-741

1 reference

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

The global distribution of clinical episodes of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

The burden of malaria mortality among African children in the year 2000.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Pre-erythrocytic malaria vaccines: towards greater efficacy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

T cells as mediators of protective immunity against liver stages of Plasmodium

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Properties of murine (CD8+)CD27- T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

A protein particle vaccine containing multiple malaria epitopes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737672

7 January 2021

Identifiers

DOI

10.1002/EJI.200737672

1 reference

17 September 2017

1 reference